Considering this, herein, we investigated one non-oncology drug named meticrane (a thiazide diuretic used to treat essential hypertension), which undescribably improved the therapeutic efficacy of anti-CTLA4 in AB1-HA tumor-bearing mice (9). The gene discussed is CTLA4; the disease is essential hypertension.